New Delhi, July 26 -- Indian pharmaceutical companies will now have access to the UK's National Health Service (NHS) procurement strategy, following a recent update under the India-UK Enhanced Trade Partnership.

This move is expected to provide Indian drug manufacturers with better insight into upcoming procurement opportunities in the UK's healthcare system.

The NHS, which is one of the world's largest publicly funded healthcare systems, spends around Euro 393 million (approximately Rs 4,200 crore) on pharmaceutical imports annually.

Indian pharma companies are already key suppliers of generic drugs and are likely to gain further ground with this increased transparency.

According to the UK government, sharing details of the NHS procu...